SCHEMBL5754424

SCHEMBL5754424

O=C1NC(Cc2cccc(CC(F)(F)C(F)F)c2)C(c2ccc(F)cc2)O1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 12/20 0.35
MDM2 Q00987 2/20 0.32
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5751976 0.85 HTR1A (0.42) GRM5
SCHEMBL5751660 0.83 CETP (0.44) GRM5
SCHEMBL5751179 0.82 DAO (0.43) GRM5
SCHEMBL5755829 0.81 EPHX1 (0.34) GRM5MDM2
SCHEMBL5749743 0.81 GRM5 (0.35) GRM5MDM2MGLL
SCHEMBL5751222 0.81 GRM5 (0.34) GRM5MDM2
SCHEMBL5753852 0.80 GRM5 (0.36) GRM5MDM2
SCHEMBL5753082 0.79 DAO (0.46) GRM5
SCHEMBL5749871 0.79 GRM5 (0.35) GRM5MDM2
SCHEMBL5755641 0.79 ATM (0.40) GRM5MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP GRM5 2869/4885MDM2 3868/4885MGLL 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.